Picot Valentina Sanchez, Bénet Thomas, Messaoudi Melina, Telles Jean-Noël, Chou Monidarin, Eap Tekchheng, Wang Jianwei, Shen Kunling, Pape Jean-William, Rouzier Vanessa, Awasthi Shally, Pandey Nitin, Bavdekar Ashish, Sanghvi Sonali, Robinson Annick, Contamin Bénédicte, Hoffmann Jonathan, Sylla Maryam, Diallo Souleymane, Nymadawa Pagbajabyn, Dash-Yandag Budragchaagiin, Russomando Graciela, Basualdo Wilma, Siqueira Marilda M, Barreto Patricia, Komurian-Pradel Florence, Vernet Guy, Endtz Hubert, Vanhems Philippe, Paranhos-Baccalà Gláucia
Emerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 21, Avenue Tony Garnier, Lyon, 69007, France.
Infection Control and Epidemiology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
BMC Infect Dis. 2014 Dec 10;14:635. doi: 10.1186/s12879-014-0635-8.
Data on the etiologies of pneumonia among children are inadequate, especially in developing countries. The principal objective is to undertake a multicenter incident case-control study of <5-year-old children hospitalized with pneumonia in developing and emerging countries, aiming to identify the causative agents involved in pneumonia while assessing individual and microbial factors associated with the risk of severe pneumonia.
METHODS/DESIGN: A multicenter case-control study, based on the GABRIEL network, is ongoing. Ten study sites are located in 9 countries over 3 continents: Brazil, Cambodia, China, Haiti, India, Madagascar, Mali, Mongolia, and Paraguay. At least 1,000 incident cases and 1,000 controls will be enrolled and matched for age and date. Cases are hospitalized children <5 years with radiologically confirmed pneumonia, and the controls are children without any features suggestive of pneumonia. Respiratory specimens are collected from all enrolled subjects to identify 19 viruses and 5 bacteria. Whole blood from pneumonia cases is being tested for 3 major bacteria. S. pneumoniae-positive specimens are serotyped. Urine samples from cases only are tested for detection of antimicrobial activity. The association between procalcitonin, C-reactive protein and pathogens is being evaluated. A discovery platform will enable pathogen identification in undiagnosed samples.
This multicenter study will provide descriptive results for better understanding of pathogens responsible for pneumonia among children in developing countries. The identification of determinants related to microorganisms associated with pneumonia and its severity should facilitate treatment and prevention.
关于儿童肺炎病因的数据并不充分,在发展中国家尤其如此。主要目标是在发展中国家和新兴国家对5岁以下因肺炎住院的儿童开展一项多中心病例对照研究,旨在确定肺炎的致病原,同时评估与重症肺炎风险相关的个体和微生物因素。
方法/设计:一项基于GABRIEL网络的多中心病例对照研究正在进行中。10个研究地点位于三大洲的9个国家:巴西、柬埔寨、中国、海地、印度、马达加斯加、马里、蒙古和巴拉圭。将招募至少1000例新发病例和1000名对照,并按年龄和日期进行匹配。病例为5岁以下经放射学确诊肺炎的住院儿童,对照为无任何肺炎迹象的儿童。从所有入选受试者中采集呼吸道标本,以鉴定19种病毒和5种细菌。对肺炎病例的全血进行3种主要细菌的检测。对肺炎链球菌阳性标本进行血清分型。仅对病例的尿液样本进行抗菌活性检测。正在评估降钙素原、C反应蛋白与病原体之间的关联。一个发现平台将能够对未确诊样本中的病原体进行鉴定。
这项多中心研究将提供描述性结果,以更好地了解发展中国家儿童肺炎的病原体。确定与肺炎及其严重程度相关的微生物决定因素应有助于治疗和预防。